Canada · Health Canada Drug Product Database
L-ASPARTIC ACID
Source ingredient · 32 source records
Names are grouped within this source and country. A shared ingredient does not establish interchangeable medicines.
20% PROSOL
Liquid / BAXTER CORPORATION
AMINOSYN II
Solution / ICU MEDICAL CANADA INC
AMINOSYN II
Solution / ICU MEDICAL CANADA INC
AMINOSYN II 10% WITH ELECTROLYTES
Solution / HOSPIRA HEALTHCARE ULC
AMINOSYN II 5% INJ
Liquid / ABBOTT LABORATORIES, LIMITED
AMINOSYN II 7% INJECTION
Solution / HOSPIRA HEALTHCARE ULC
AMINOSYN II 7% M IN 10% DEXTROSE(DUAL CHAMBER)
Solution / HOSPIRA HEALTHCARE ULC
AMINOSYN II 7% WITH 10% DEXTROSE
Solution / HOSPIRA HEALTHCARE ULC
AMINOSYN II 7% WITH 50% DEXTROSE
Solution / HOSPIRA HEALTHCARE ULC
AMINOSYN II 8.5% INJECTION
Solution / HOSPIRA HEALTHCARE ULC
AMINOSYN II 8.5% M IN 20% DEXTROSE (DUAL CHAMBER)
Solution / HOSPIRA HEALTHCARE ULC
AMINOSYN II 8.5% WITH 50% DEXTROSE
Solution / HOSPIRA HEALTHCARE ULC
AMINOSYN II IN DEXTROSE INJECTION
Solution / HOSPIRA HEALTHCARE ULC
AMINOSYN II IN DEXTROSE INJECTION
Solution / HOSPIRA HEALTHCARE ULC
AMINOSYN II IN DEXTROSE INJECTION
Solution / HOSPIRA HEALTHCARE ULC
AMINOSYN II WITH ELECTROLYTES IN DEXTROSE INJECTION WITH CALCIUM
Solution / HOSPIRA HEALTHCARE ULC
AMINOSYN II WITH ELECTROLYTES IN DEXTROSE INJECTION WITH CALCIUM
Solution / HOSPIRA HEALTHCARE ULC
AMINOSYN II WITH ELECTROLYTES IN DEXTROSE WITH CALCIUM
Solution / HOSPIRA HEALTHCARE ULC
AMINOSYN-PF 10%
Solution / HOSPIRA HEALTHCARE ULC
AMINOSYN-PF 7%
Solution / HOSPIRA HEALTHCARE ULC
OLIMEL 3.3% E
Emulsion / BAXTER CORPORATION
OLIMEL 4.4%
Emulsion / BAXTER CORPORATION
OLIMEL 4.4% E
Emulsion / BAXTER CORPORATION
OLIMEL 5.7%
Emulsion / BAXTER CORPORATION
OLIMEL 5.7% E
Emulsion / BAXTER CORPORATION
OLIMEL 7.6%
Emulsion / BAXTER CORPORATION
OLIMEL 7.6% E
Emulsion / BAXTER CORPORATION
PERIOLIMEL 2.5% E
Emulsion / BAXTER CORPORATION
PRIMENE 10%
Liquid / BAXTER CORPORATION
PRIMENE 10%-LIQ IV
Liquid / CLINTEC NUTRITION COMPANY